Tessera Therapeutics
Focus: Tessera Therapeutics is a gene-writing biotech company focused on rare diseases and gene therapy, headquartered in Somerville, MA. The company is at an early clinical stage with a single Phase 1/2 program in development.
Profile data last refreshed 15h ago · AI intelligence enriched 2w ago
Open Jobs
2
5 recent layoff filings (12 mo) — 168 affected
- 1/12/2026 — Unknown/Unknown, OH · 1 affected · Layoff
- 1/7/2026 — Somerville, MA · 82 affected · Layoff
- 1/7/2026 — Remote, CT · 1 affected · Layoff
- +2 more
Source: state DOL filings via Big Local News
Should You Work at Tessera Therapeutics?
AI assessmentTessera is a speculative early-stage play best suited to scientists and operators comfortable with gene-therapy risk in exchange for potential upside in an emerging modality.
Why Work Here
- Ground-floor opportunity in gene-writing technology, an emerging modality with significant intellectual property potential
- Focused rare disease strategy reduces competitive pressure and enables deeper expertise building in specialized indications
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
PHASE_1_2
Clinical Trials (1)
NCT07227207A Study of TSRA-196 in Adults With PiZZ Alpha-1 Antitrypsin Deficiency (AATD)
Phase 1/2Help build intelligence for Tessera Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.